How Long Is CJC-1295 (No DAC) Good For After Reconstitution?

Quick Answer: CJC-1295 (No DAC) Reconstitution Shelf Life

In a controlled laboratory environment, reconstituted CJC-1295 (No DAC) maintains full primary structure and biological potency for 21 to 28 days when stored at refrigerated temperatures between 2°C and 8°C (36°F to 46°F) using 0.9% benzyl alcohol preserved bacteriostatic water. If reconstituted using sterile water without an antimicrobial agent, the solution should be utilized within 24 hours to prevent microbial accumulation and enzymatic hydrolytic degradation.

Un-reconstituted lyophilized powder stored at -20°C remains stable for up to 24 months. Once liquid diluent is introduced, temperature fluctuations, light exposure, and agitation drastically accelerate peptide bond cleavage and oxidation. Researchers studying cjc 1295 must adhere to strict cold-chain handling, gentle reconstitution mixing protocols, and light-shielded storage to preserve target assay consistency.

What Is the Reconstituted Stability Timeline for CJC-1295 (No DAC)?

When evaluating how long is cjc-1295 (no dac) good for after reconstitution, investigators must separate physical appearance from chemical stability. Peptide degradation occurs primarily via deamidation, oxidation of sensitive residues, and hydrolysis of the peptide backbone. While a reconstituted solution may remain visibly clear, silent molecular degradation reduces the concentration of active peptide over time.

Under refrigerated storage (2–8°C) in bacteriostatic water, high-purity CJC-1295 (No DAC) vials retain >95% purity for up to 21 days, slowly degrading toward 90% purity near day 28. Beyond 30 days, accumulated deamidation products can interfere with receptor binding affinity in GHRH assays.

At room temperature (20–25°C), reconstituted cjc no dac degrades rapidly. Chemical degradation accelerates exponentially at ambient temperatures, resulting in a loss of up to 5% purity per 24-hour period. Exposure to temperatures above 37°C can cause rapid denaturing and precipitation within hours. Consequently, reconstituted solutions should never remain at room temperature longer than necessary to perform laboratory pipetting.

How Does Diluent Selection Affect CJC-1295 (No DAC) Shelf Life?

The choice of reconstitution diluent is the primary factor governing liquid shelf life. The two most common diluents evaluated in preclinical settings are Bacteriostatic Water (0.9% Benzyl Alcohol) and Sterile Water for Injection (0.9% Sodium Chloride or pure H2O).

Bacteriostatic Water is the standard choice for multi-use laboratory vials. The 0.9% benzyl alcohol preservative inhibits bacterial contamination introduced during repeat syringe punctures. Furthermore, the mild bacteriostatic environment slows secondary hydrolytic reactions without disrupting the peptide's helical structure, supporting the 21-to-28-day refrigerated stability window.

Sterile Water for Injection lacks a preservative. Once the vial stopper is pierced, airborne microbes or container contact can introduce bacteria that metabolize the peptide chain. Unpreserved solutions must be drawn and utilized in single-use assays immediately or discarded within 24 hours. Normal Saline (0.9% NaCl) can also be utilized for immediate acute assays, but ionic strength adjustments may alter long-term solubility compared to bacteriostatic water.

What Protocol Best Preserves CJC-1295 (No DAC) Chemical Structure During Reconstitution?

The mechanical technique used during reconstitution directly impacts physical stability and initial yield. Synthetic peptides are fragile, unstructured chains that can aggregate or shear under excessive kinetic energy.

To reconstitute order 5 mg vials of CJC-1295 (No DAC), direct the diluent stream against the glass wall of the vial rather than forcing liquid directly onto the lyophilized cake. Allowing the diluent to gently run down the inner wall prevents rapid foaming and mechanical shear stress. Let the vial sit undisturbed at room temperature for 2 to 5 minutes to allow natural hydration.

Never shake or vortex a freshly reconstituted peptide vial. Violent agitation introduces air bubbles that denature hydrophobic regions of the peptide chain, leading to irreversible aggregation and visible precipitation. Instead, slowly roll the vial between your palms or gently invert it 3 to 5 times until the solution is completely transparent.

Why Should Reconstituted Peptides Be Aliquoted to Avoid Freeze-Thaw Cycles?

A common point of confusion in laboratory peptide management is whether reconstituted CJC-1295 (No DAC) can be frozen to extend shelf life. While freezing un-reconstituted lyophilized powder at -20°C or -80°C is standard procedure, freezing liquid solutions presents distinct risks.

Repeated freeze-thaw cycles form ice microcrystals that tear apart tertiary peptide structure, inducing mechanical cleavage and severe aggregation upon thawing. If a reconstituted solution must be preserved for extended periods exceeding 30 days, it should be aliquoted immediately after reconstitution into single-use microcentrifuge tubes.

Aliquoting involves dividing the reconstituted batch into individual experimental volumes prior to freezing. This strategy ensures that each aliquot undergoes exactly one freeze-thaw cycle upon unfreezing for assay use. Furthermore, freezing liquid bacteriostatic water can occasionally lead to phase separation of benzyl alcohol; thus, aliquoted freezing is recommended primarily for high-concentration stock solutions prepared in sterile water or specialized buffer formulations.

What Are the Visual Signs That Reconstituted CJC-1295 (No DAC) Has Degraded?

Prior to initiating any in vitro or animal model assay, researchers should perform a visual inspection of the reconstituted solution. Fully intact CJC-1295 (No DAC) dissolves into a crystal-clear, colorless liquid free of floating particles.

Visible indicators of physical degradation or contamination include turbidity (cloudiness), persistent floaters, fine particulate precipitation, or color shift toward yellow. Turbidity indicates hydrophobic peptide aggregation or microbial growth. If any visual abnormality is present after gentle inversion, the vial should be retired from research use.

It is vital to note that chemical degradation—such as single-amino-acid oxidation or deamidation—does not always alter solution clarity. A vial may appear perfectly clear despite having lost significant biological potency after 40 days in storage. Adhering strictly to established stability timeframes and sourcing from high-purity catalog offerings ensures experimental consistency.

How Do Initial Purity and Endotoxin Levels Impact Solution Stability?

The chemical stability of reconstituted CJC-1295 (No DAC) is directly proportional to its initial synthesis purity and post-purification processing. Residual manufacturing impurities acts as autocatalytic agents that accelerate peptide degradation once dissolved.

Traces of trifluoroacetic acid (TFA) salts left over from reverse-phase HPLC purification reduce solution pH, increasing hydrolytic cleavage rates. Heavy metal catalysts and bacterial endotoxins (lipopolysaccharides) also destabilize amide bonds in liquid media. Peptides synthesized at lower purity thresholds (e.g., <95%) undergo significantly faster degradation in liquid form than research-grade peptides refined to ≥99% purity.

PX1 Research ensures that every batch of CJC-1295 (No DAC) undergoes rigorous lyophilization to remove volatile organic solvents and achieves ultralow residual TFA and endotoxin levels (<0.5 EU/mg). High initial purity acts as a protective buffer against rapid chemical decay upon liquid reconstitution.

What Is CJC-1295 (No DAC) and How Is It Studied in Preclinical Research?

CJC-1295 (No DAC)—also designated as Modified GRF 1-29—is a 29-amino-acid tetrasubstituted synthetic peptide analog of endogenous growth hormone-releasing hormone (GHRH). By substituting specific amino acids at positions 2, 8, 15, and 27, the molecule achieves enhanced resistance to dipeptidyl peptidase-4 (DPP-IV) enzymatic cleavage compared to native GHRH 1-29.

In laboratory models, CJC-1295 (No DAC) is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research. Unlike CJC-1295 with DAC (Drug Affinity Complex), which binds serum albumin to extend half-life to several days, CJC-1295 (No DAC) exhibits a shorter biological half-life (approximately 30 minutes in vivo), allowing researchers to mimic physiological pulsatile GH release patterns.

In preclinical study design, cjc no dac is frequently evaluated alongside selective growth hormone secretagogues like Ipamorelin. Researchers often investigate co-administration protocols involving cjc ipamorelin combinations to observe potential synergistic activation of both GHRH and ghrelin/GHSR receptors in cell culture and animal models.

Comparing Supplier Criteria for Peptide Reconstitution Stability

When purchasing GHRH analogs for precise shelf-life and degradation experiments, researchers must evaluate vendor specifications. Below is an objective criteria matrix for vetting supplier quality and reconstitution reliability:

1. Purity Verification: Require lot-specific High-Performance Liquid Chromatography (HPLC) chromatograms demonstrating ≥99.0% main peak area.

2. Structural Identity: Require Mass Spectrometry (MS) mass-to-charge verification matching the exact molecular weight of CJC-1295 (No DAC) (3367.9 Da).

3. Endotoxin Quantitation: Verify kinetic chromogenic LAL analysis demonstrating endotoxin levels under 0.5 EU/mg to prevent baseline cell culture inflammation.

4. Lyophilization Integrity: Ensure the lyophilized cake is uniform, white, and free of collapse or moisture intrusion prior to reconstitution.

5. Transit Protection: Cold-chain or thermally protected domestic shipping prevents thermal degradation during summer transport.

Red Flags to Avoid When Sourcing Research Peptides for Stability Studies

Selecting lower-grade peptides undermines research repeatability and distorts stability testing. Be vigilant against common vendor red flags:

1. Generic or Pooled COAs: Vendors providing static PDF certificates of analysis that do not match the exact lot number printed on your vial.

2. Missing Endotoxin Data: Suppliers that report purity percentages but omit bacterial endotoxin or residual solvent assays.

3. Undefined Purity Claims: Marketing phrases like '98%+ pure' without accessible raw HPLC chromatograms showing integration baseline numbers.

4. Inadequate Packaging: Vials shipped in unpadded envelopes without desiccants or temperature protection, exposing lyophilized cake to humidity and heat spikes.

5. Absence of Domestic Synthesis Integrity: Distributors that import bulk unverified powders without performing secondary US-based batch verification.

Ordering CJC-1295 (No DAC) from PX1 Research

PX1 Research provides high-purity, USA-synthesized CJC-1295 (No DAC) packaged in sterile, vacuum-sealed glass vials designed specifically for demanding in vitro and preclinical research applications. Each lot undergoes comprehensive third-party HPLC, Mass Spectrometry, and Endotoxin analysis, with full laboratory documentation accessible directly on our platform.

Vials are available in standard 2 mg and 5 mg mass options, featuring robust rubber stoppers compatible with standard reconstitution diluents. Orders placed before 2:00 PM PST Monday through Friday dispatch same-day from our California or Arizona fulfillment centers with tracked domestic transit to maintain supply chain thermal integrity.

To review full analytical documentation or purchase verified reference materials for your laboratory, explore our CJC-1295 (No DAC) product page or contact our research support team for bulk inquiries.